InMed special meeting lacks quorum for share issuance vote; appoints new auditor CBIZ

InMed Pharmaceuticals Inc.

Special meeting on June 13, 2025 lacked quorum; ~60% of voted shares favored share issuance proposal but no vote held. Board evaluating next steps.
Marcum resigned as auditor after acquisition by CBIZ; Board appointed CBIZ as independent auditor for FY2025. No disagreements; prior material weakness remediated.
Company amended SEPA with Yorkville to allow suspension of registration statement during black-out periods, subject to restrictions similar to insider trading policies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.